Literature DB >> 2899237

Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya.

W M Watkins1, J A Oloo, J D Lury, M Mosoba, D Kariuki, M Mjomba, D K Koech, H M Gilles.   

Abstract

Halofantrine hydrochloride given to 46 Kenyan children with falciparum malaria at 10 mg/kg for two doses, and to 60 other children at 8 mg/kg for three doses, resulted in rapid parasite clearance, mean parasite clearance times being 45.4 h and 54.8 h, respectively. In-vitro chemosensitivity tests showed that most infections were due to chloroquine-resistant parasites, and that parasite maturation was inhibited by considerably lower concentrations of halofantrine than of chloroquine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899237     DOI: 10.1016/s0140-6736(88)92538-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  Antimalarial pharmacokinetics and treatment regimens.

Authors:  N J White
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

2.  Pharmacokinetics of halofantrine in man: effects of food and dose size.

Authors:  K A Milton; G Edwards; S A Ward; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

3.  Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.

Authors:  J Karbwang; K A Milton; K Na Bangchang; S A Ward; G Edwards; D Bunnag
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 4.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

5.  Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.

Authors:  Yetunde T Kolade; Chinedum P Babalola; Ajibola A Olaniyi; Gerhard K E Scriba
Journal:  Eur J Clin Pharmacol       Date:  2007-10-20       Impact factor: 2.953

6.  Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon.

Authors:  G Fadat; F J Louis; J P Louis; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 7.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

8.  Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.

Authors:  W M Watkins; P A Winstanley; E K Mberu; G Kokwaro; S A Murphy; C J Newton; I Mwangi; D Forster; K Marsh
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of halofantrine.

Authors:  J Karbwang; K Na Bangchang
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.

Authors:  G Edwards; P A Winstanley; S A Ward
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.